Drug Trial Radar · NCT06679985
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Dec 20, 2024
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Coherus Oncology, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for casdozokitug in combination with toripalimab plus bevacizumab.
Conditions
- Hepatocellular Carcinoma
Interventions
CasdozokitugDrug
Solution for infusion
ToripalimabDrug
Solution for infusion
BevacizumabDrug
Solution for infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: From date of first dose to 90 days after date of last dose (Up to approximately 27 months)
- Objective Response Rate (ORR) by Investigator Review According to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1Time frame: Up to approximately 2 years
Locations
44 sites in 6 countries. Site status is shown where the registry gives one.
Mayo Clinic - Scottsdale
Scottsdale, Arizona
University of Arizona - Cancer Center
Tucson, Arizona
Beverly Hills Cancer Center
Beverly Hills, California
City of Hope
Duarte, California
City of Hope at Irvine Lennar
Irvine, California
Cancer & Blood Specialty Clinic
Lakewood, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
Sarcoma Oncology Center
Santa Monica, California
Mayo Clinic - Jacksonville
Jacksonville, Florida
The Winship Cancer Institute Emory University
Atlanta, Georgia
Mountain States Tumor Institute at St. Luke's Regional Medical Center
Boise, Idaho
University of Kansas Cancer Center
Kansas City, Kansas
UofL Health Brown Cancer Center
Louisville, Kentucky
University of Mississippi Medical Center
Jackson, Mississippi
Christus St. Vincent Regional Medical Center
Santa Fe, New Mexico
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York
Montefiore Medical Center
The Bronx, New York
University of North Carolina (UNC) - Chapel Hill
Chapel Hill, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James)
Columbus, Ohio
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
Pittsburgh, Pennsylvania
Prisma Health Cancer Institute
Greenville, South Carolina
Virginia Cancer Specialists
Fairfax, Virginia
Virginia Oncology Associates
Norfolk, Virginia
UW Carbone Cancer Center - Cancer Connect
Madison, Wisconsin
St Vincent's Hospital Sydney
Darlinghurst, Australia
Linear Clinical Research
Nedlands, Australia
Royal Brisbane and Women's Hospital
Herston, Brisbane, Australia
Bankstown-Lidcombe Hospital
Bankstown, New South Wales, Australia
Monash Health
Melbourne, Victoria, Australia
Sunnybrook Health Sciences Centre - Bayview Campus
Toronto, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Humanity & Health Clinical Trial Centre
Hong Kong, Hong Kong
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
Queen Mary Hospital
Hong Kong, Pok Fu Lam, Hong Kong
National Cancer Centre Singapore
Singapore, Singapore
Tan Tock Seng Hospital
Singapore, Singapore
Curie Oncology
Singapore, Singapore
Chi Mei Medical Center
Tainan, Taiwan
Linkou Chang Gung Memorial Hospital (CGMHLK)
Taoyuan City, Taiwan
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.